459 related articles for article (PubMed ID: 20101721)
1. Transgenic mouse models of Alzheimer's disease.
Elder GA; Gama Sosa MA; De Gasperi R
Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721
[TBL] [Abstract][Full Text] [Related]
2. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models.
Schaeffer EL; Figueiro M; Gattaz WF
Clinics (Sao Paulo); 2011; 66 Suppl 1(Suppl 1):45-54. PubMed ID: 21779722
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice as a model for Alzheimer's disease.
Lithner CU; Hedberg MM; Nordberg A
Curr Alzheimer Res; 2011 Dec; 8(8):818-31. PubMed ID: 21592052
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer disease: amyloidogenesis, the presenilins and animal models.
Newman M; Musgrave IF; Lardelli M
Biochim Biophys Acta; 2007 Mar; 1772(3):285-97. PubMed ID: 17208417
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
Suh YH; Checler F
Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
[TBL] [Abstract][Full Text] [Related]
6. Presenilins and the gamma-secretase: still a complex problem.
Small DH; Klaver DW; Foa L
Mol Brain; 2010 Feb; 3():7. PubMed ID: 20181106
[TBL] [Abstract][Full Text] [Related]
7. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
Van Broeck B; Van Broeckhoven C; Kumar-Singh S
Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.
Kokjohn TA; Roher AE
Alzheimers Dement; 2009 Jul; 5(4):340-7. PubMed ID: 19560104
[TBL] [Abstract][Full Text] [Related]
9. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
10. Sorting Out Presenilins in Alzheimer's Disease.
Wolfe MS; Yankner BA
Cell; 2016 Jun; 166(1):13-5. PubMed ID: 27368096
[TBL] [Abstract][Full Text] [Related]
11. [Selected mice models based on APP, MAPT and presenilin gene mutations in research on the pathogenesis of Alzheimer's disease].
Więdłocha M; Stańczykiewicz B; Jakubik M; Rymaszewska J
Postepy Hig Med Dosw (Online); 2012 Jun; 66():415-30. PubMed ID: 22922141
[TBL] [Abstract][Full Text] [Related]
12. Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.
Li X; Quan M; Wei Y; Wang W; Xu L; Wang Q; Jia J
Sci China Life Sci; 2023 Dec; 66(12):2711-2754. PubMed ID: 37480469
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.
Stokin GB; Almenar-Queralt A; Gunawardena S; Rodrigues EM; Falzone T; Kim J; Lillo C; Mount SL; Roberts EA; McGowan E; Williams DS; Goldstein LS
Hum Mol Genet; 2008 Nov; 17(22):3474-86. PubMed ID: 18694898
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.
Harasta AE; Ittner LM
Adv Neurobiol; 2017; 15():3-29. PubMed ID: 28674976
[TBL] [Abstract][Full Text] [Related]
15. [The phenotypes of APPswe/PS1dE9 double transgenic mice].
Cui YQ; Zheng Y; Wang XM
Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):211-5. PubMed ID: 23019926
[No Abstract] [Full Text] [Related]
16. [Molecular basics of Alzheimer's disease].
Grigorenko AP; Rogaev EI
Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
[TBL] [Abstract][Full Text] [Related]
17. Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis.
Micotti E; Paladini A; Balducci C; Tolomeo D; Frasca A; Marizzoni M; Filibian M; Caroli A; Valbusa G; Dix S; O'Neill M; Ozmen L; Czech C; Richardson JC; Frisoni GB; Forloni G
Neurobiol Aging; 2015 Feb; 36(2):776-88. PubMed ID: 25433456
[TBL] [Abstract][Full Text] [Related]
18. MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilins.
Tachi N; Hashimoto Y; Matsuoka M
Biochem J; 2012 Mar; 442(2):413-22. PubMed ID: 22115042
[TBL] [Abstract][Full Text] [Related]
19. The amyloid peptide and its precursor in Alzheimer's disease.
Octave JN
Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
[TBL] [Abstract][Full Text] [Related]
20. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
Li C; Ebrahimi A; Schluesener H
Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
